Live Breaking News & Updates on Sound Bioventures

Stay updated with breaking news from Sound bioventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

VarmX Promotes CSO Dr. Jeffrey Lawson to New CEO and Moves to New State-of-the-Art Facility

VarmX Promotes CSO Dr. Jeffrey Lawson to New CEO and Moves to New State-of-the-Art Facility
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Duke University , North Carolina , Pieter Reitsma , Lundbeckfonden Biocapital , Fxa Doacs , Jeffrey Lawson , Leiden University Medical Center , Life Sciences , Chief Scientific Officer , Vice Chair , Clinical Trials , Duke University Medical , United State , Professor Pieter Reitsma , Sound Bioventures , Ysios Capital , Biogeneration Ventures , Giulia Lasagni , Batoul Ali ,

Avalyn's New Twist on Older Lung Disease Drugs Attracts $175M for Clinical Trials

Avalyn Pharma aims to improve treatment of Idiopathic pulmonary fibrosis with inhalable versions of two older oral drugs and it’s now headed for mid-stage testing backed by a Series C financing. Other recent biotech industry financings raised money for research in cancer, immunology, and rare genetic diseases. ....

Menlo Park , United States , Rock Springs , New Zealand General , New Zealand , Avalyn Pharma , Lyn Baranowski , Hyku Biosciences , Newton Biocapital , Acesion Pharma , Harbinger Health , Novartis Venture Fund , T Rowe Price Associates , Novo Holdings , Fidelity Management Research Company , Perceptive Xontogeny Venture Funds , Eventide Asset , Vida Ventures , Wellington Management , Rock Springs Capital , Price Associates , Surveyor Capital , Catalio Capital Management , Norwest Venture Partners , F Prime Capital , Venture Partners ,

Golgi Neurosciences; Breye Therapeutics: Golgi Neurosciences and Breye Therapeutics announce successful closing of P2X7 receptor antagonist program transfer

Golgi Neurosciences; Breye Therapeutics: Golgi Neurosciences and Breye Therapeutics announce successful closing of P2X7 receptor antagonist program transfer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Chiara Liberati , Ulrik Mouritzen , Novo Holdings , Danish Growth Foundation , Bioinnovation Institute , Danish Innovation Foundation Innovationsfonden , Breye Therapeutics Aps , Related Macular Degeneration , Managing Director , Golgi Neurosciences , Scientific Advisory Board , Chief Executive Officer , Breye Therapeutics , Amyotrophic Lateral Sclerosis , Multiple Sclerosis , Diabetic Retinopathy , Age Related Macular Degeneration , Sound Bioventures , Danish Innovation Foundation , Die Experten ,

Golgi Neurosciences and Breye Therapeutics announce successful closing of P2X7 receptor antagonist program transfer

/PRNewswire/ Golgi Neurosciences S.r.l., the biotech incubator dedicated to the development of new treatments for devastating diseases, and Breye. ....

Ulrik Mouritzen , Chiara Liberati , Novo Holdings , Bioinnovation Institute , Danish Innovation Foundation Innovationsfonden , Danish Growth Foundation , Breye Therapeutics Aps , Related Macular Degeneration , Managing Director , Golgi Neurosciences , Scientific Advisory Board , Chief Executive Officer , Breye Therapeutics , Amyotrophic Lateral Sclerosis , Multiple Sclerosis , Diabetic Retinopathy , Age Related Macular Degeneration , Sound Bioventures , Danish Innovation Foundation , Golgi Neurosciences Breye Therapeutics ,

VarmX raises funds to obtain IND approval for VMX-C001

Biotechnology company VarmX has raised an additional €30m in a Series B2 financing round to obtain IND approval for its lead compound VMX-C001. ....

Lundbeckfonden Biocapital , European Innovation Council , Life Sciences , Libertatis Ergo Holding , Sound Bioventures , Ysios Capital , Biogeneration Ventures ,